chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 2/16/2021 The doctors asked me to pull to side because they knew I had anaphylaxis. The doctor stood next to me and injected me with an EpiPen through my pants immediately and my husband immediately took me to the ER. I do not recall much and the allergic reaction was within 10-15 minutes. I turned to my husband and told him I was going to pass out and I did. I got hives and itchy throat. At the ER I was put on particular steroids he also gave me something to calm down but I don't remember. I did do a follow-up with the doctor by phone and I was told to call if needed.
C/O itching at MMR injection site; flushed; eyes became red; c/o difficulty breathing; emesis x 3; warm and clammy; hypotensive.
Patient received ADACEL and FLUARIX in the right arm and came down with a cellulitis infection. Patient's dr says site of infection was too far down in the arm. Patient's arm was swollen and had to go to have a dr visit resulting in a prescription for BACTRIM DS.
All of the current symptoms as mentioned in drug information (no diarrhea) but also two episodes of vertigo. And the symptoms were not relieved by medicine (tried Tylenol for fever/headache, Zofram for vomiting, etc.). Possibly because injection was so close in date to having COVID? All side effects lasted about 30 hours. After that, only headache and fatigue remained for another 24 hours
Headache, Fever, chills, sweating,arm sore,sore throat, stomach nausea mild (intermittent) Narrative:
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 2013, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent and severe strain of herpes zoster. On an unknown date after receiving ZOSTAVAX, the patient was diagnosed with shingles inside his left eye and on his forehead, which contributed to diminished eyesight and sensitivity to light. The patient continues to suffer from residual pain in his left eye, along with left eye discomfort and dryness. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, persistent strain of herpes zoster/shingles inside his left eye and on his forehead was determined to be medically significant. Additional information has been requested.
11 hours: Headache, fever, chills, nausea, fatigue, inability to focus, general feeling of unwellness 20 hours: Fever breaks 24 hours: Fever returns. Other symptoms begin to lessen. 36 hours: Fever breaks. Other symptoms continue to diminish 48 hours: All symptoms gone, except for mild fatigue and inability to focus 60 hours: All symptoms gone
Instructed by Moderna to fill out a VAERS.  No adverse outcome occurred.  This patient received a vaccine that was removed from deep freeze beyond the date of recommended use.  The Beyond use date is 10/24/2021 and vaccine was given to patient on 10/27/2021.
red and sore; tenderness; horrible rash and it itches; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (horrible rash and it itches), VACCINATION SITE ERYTHEMA (red and sore) and VACCINATION SITE PAIN (tenderness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced RASH PRURITIC (horrible rash and it itches). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red and sore) and VACCINATION SITE PAIN (tenderness). At the time of the report, RASH PRURITIC (horrible rash and it itches) had not resolved, VACCINATION SITE ERYTHEMA (red and sore) outcome was unknown and VACCINATION SITE PAIN (tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided by reporter.  No treatment information provided by reporter.   Reporter did not allow further contact
1418  Patient sitting in general observation and began feeling dizzy/lightheaded. Color pale. Offered water and drank without difficulty. States she is also beginning to feel nauseated. Taken via w/c to private observation area. HR 78; O2 98% on room air. BP 117/75. Had patient remove mask and opened outside doors. Encouraged patient to deep breath. Patient's hands shaky. Denies shortness of breath, throat discomfort, itching. Continued  to encourage to drink water. EMT in attendance.  1433: patient states she no longer feels dizzy, but still nauseated and still shaking per bilateral arms, hands. She states that is not normal. Appears to be having chills. BP 100/69; H R 73: O2 96% on room air. States she wants to walk to car, husband present.  1446: Stood independently and assessed . States she does not feel dizzy and ambulated with husband to personal vehicle.
HEADACHE, CHILLS, FEVER, MATALLIC TASTE, NAUSEA, FATIGUE, AND COLD SWEATS.
At about 12 minutes after vaccine, pt said her chest felt heavy and breathing labored.  We chatted and joked around, and she was intermittently ok, then symptomatic.  Sx progressed very slowly over about 30 minutes, when she finally said sx were getting much worse and she felt like she was having trouble getting air in.  Medics called and one dose of epi was given, pt said she felt immediately better, but by the time medics arrived, pt was symptomatic again.  She was taken to ER in stable condition.
immediate nausea, headache, dizziness (feeling of motion sickness) and arm pain, tiredness. ongoing headaches, fatigue, dizziness and nausea on and off every day
Awoke 12 hours after injection with fever of 101degF, chills, muscle and joint aches, severe headache and nausea. Breathing was shallow, and face, hands, arms were pasty yellow/white. My husband kept checking me to be sure I was breathing as he thought at times I might have died. I was awake throughout but very weak and dizzy. O2 sat checked with a pulse oximeter was 96%, and blood pressure 98/61. I began to recover 30 hours after injection, and was weak for a couple of days afterward, and then felt ok. I am fine now.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received BNT162b2 (BNT162B2), on 13Apr2021 at 14:00 as dose 1, single (Batch/Lot number: unknown), in right arm, on 04May2021 at 13:00 as dose 2, single (Batch/Lot number: unknown), in left arm and on 22Dec2021 at 14:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not receive any other medication in 2 weeks. Paxlovid was used as treatment for COVID-19. Patient received previous covid 19 vaccine. Patient not taking any other medications/products within 2 weeks of starting COVID-19 treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Received a full 3rd dose despite not being immunocompromised; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Received a full 3rd dose despite not being immunocompromised) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced ACCIDENTAL OVERDOSE (Received a full 3rd dose despite not being immunocompromised). At the time of the report, ACCIDENTAL OVERDOSE (Received a full 3rd dose despite not being immunocompromised) outcome was unknown.            No concomitant medications were reported. It was reported that patient received a full third dose despite not being immunocompromised. No treatment details were reported.   Reporter did not allow further contact
Unexplained weakness and fatigue since having the injection of H1N1 on 10-21-09. Seen OB/GYN. No treatment. 10/29/2009 MD records from  OB-GYN 10/28/2009. States that patient was seen in ED on 10/26/2009 for c/o's weakness and fatigue post vaccine. DR's notes state that labs were normal with exception of low potassium.
Tingling sensation on the left arm; Numbness on the left arm; Pain from shoulder to the fingers on the left side; Dizziness; About to throw up; Chills; Fever; Headache; Weakness; Stiffness in the neck; Stiffness in the shoulder; Stiffness in the back; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), MUSCULOSKELETAL STIFFNESS (Stiffness in the neck), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder), MUSCULOSKELETAL STIFFNESS (Stiffness in the back) and PARAESTHESIA (Tingling sensation on the left arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A. and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced ASTHENIA (Weakness), MUSCULOSKELETAL STIFFNESS (Stiffness in the neck), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder), MUSCULOSKELETAL STIFFNESS (Stiffness in the back), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 08-Apr-2021, the patient experienced DIZZINESS (Dizziness). 08-Apr-2021, the patient experienced VOMITING (About to throw up). On 09-Apr-2021, the patient experienced PARAESTHESIA (Tingling sensation on the left arm). 09-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness on the left arm) and PAIN IN EXTREMITY (Pain from shoulder to the fingers on the left side). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, ASTHENIA (Weakness), MUSCULOSKELETAL STIFFNESS (Stiffness in the neck), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder), MUSCULOSKELETAL STIFFNESS (Stiffness in the back), PARAESTHESIA (Tingling sensation on the left arm), HYPOAESTHESIA (Numbness on the left arm), PAIN IN EXTREMITY (Pain from shoulder to the fingers on the left side), DIZZINESS (Dizziness), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (About to throw up) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up received on 12-APR-2021 contains Treatment medications Tylenol and Advil were added. Events were updated. On 30-Jun-2021: Follow-up received on 30-JUN-2021 contains No New Information.
Constipated very bad; stomach was not good; felt nauseas; This spontaneous case was reported by a consumer and describes the occurrence of CONSTIPATION (Constipated very bad), ABDOMINAL DISCOMFORT (stomach was not good) and NAUSEA (felt nauseas) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONSTIPATION (Constipated very bad), ABDOMINAL DISCOMFORT (stomach was not good) and NAUSEA (felt nauseas). At the time of the report, CONSTIPATION (Constipated very bad), ABDOMINAL DISCOMFORT (stomach was not good) and NAUSEA (felt nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No Treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-098355 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: On !8-May-2021, follow up document was attached which contains Batch numbers of both the doses, Events ( Stomach problem, Stomach cramps, Constipated again after 2nd dose ) after second dose.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098355:2nd dose case
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 08Apr2021 as dose 1, single (Lot number: EW0153), on 29Apr2021 as dose 2, single (Lot number: EW0121), on 12Aug2021 as dose 3 (booster), single (Lot number: FC3181) and on 31Mar2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 55 years for covid-19 immunisation. The patient's relevant medical history included: "Common Variable Immune Deficiency and chronic rhinitis" (unspecified if ongoing), notes: Common Variable Immune Deficiency, and chronic rhinitis; "Chronic rhinitis" (unspecified if ongoing), notes: Common Variable Immune Deficiency, and chronic rhinitis. The patient had no known allergies. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 28Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Jun2022) Positive, notes: I tested positive for covid on 28Jun2022; (07Jul2022) Negative, notes: I tested negative on a rapid test on 07Jul2022 and 08Jul2022; (08Jul2022) Negative, notes: I tested negative on a rapid test on 07Jul2022 and 08Jul2022; (11Jul2022) Positive, notes: By 11Jul2022, I wasn't feeling 100% and took a rapid test and tested positive again. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient did not receive any other medication within 2 weeks. The reporter stated that I tested positive for covid on 28Jun2022. Doctor prescribed PAXLOVID for COVID-19 treatment. I started a course on 30Jun2022 and completed on 05Jul2022. By 11Jul2022, I tested positive again. Symptoms are mild head cold like symptoms and are very similar to the initial onset symptoms. On 29Jun2022, He had a fever but did not experience a fever the second time. First time, the patient did not lose taste or smell, second time he cannot taste or smell.
SHORTLY AFTER RECEIVING THE HPV IMMUNIZATION FOLLOWED ALMOST IMMEDIATELY BY THE MENINGOCOCCAL IMMUNIZATION, THE PATIENT BECAME LIGHTHEADED, DIZZY AND SLID OFF THE EXAM TABLE TO THE FLOOR. SHE AROUSED WITHIN ONE MINUTE.  SHE WAS DIAPHORETIC, FELT NAUSEATED AND CLAMMY.  VITAL SIGNS AT THAT TIME WERE PULSE: 88  BP: 110/64.
On 10/16/2021 I woke up with sciatica extreme pain. I cant get out of bed, cant walk or stand. I have been to doctors offices and to the Emergency Room. I was diagnosed sciatica, tendinitis, bursitis
COVID 19 Treatment; COVID 19 Treatment; Dose #1, 2, 3, 5: Moderna; Dose #4: Pfizer / BioNTech; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient received bnt162b2 (BNT162B2), on 09Sep2022 as dose 4 (booster), single (Lot number: FM9992), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 16Mar2021 as dose 1, single (Lot number: 027a21a), on 12Apr2021 as dose 2, single (Lot number: 0271a21a), on 29Nov2021 as dose 3 (booster), single (Lot number: 031HZIA) and on 07Apr2023 as dose 5 (booster), single (Lot number: AS7145B), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 09Sep2022, outcome "unknown", described as "Dose #1, 2, 3, 5: Moderna; Dose #4: Pfizer / BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 01Oct2023 to 05Oct2023.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown demographics.  On an unknown date in 2013 the patient was vaccinated with MMR II. The medical assistant reported that, multiple unspecified patients were administered with MMR II that was exposed to unspecified temperature excursions from January 2013 to the present. No adverse effects were reported. This case is linked to 1401USA000055, 1401USA000056, 1312USA012478 (same reporter). Additional information has been requested.
Radiating left arm, neck nerve/muscle pain, patient not sure if related to vaccination or to exercise, pinched nerve, etc.  Patient presented to urgent care due to discomfort, being unable to sleep lying down until last night (2/26/20).  Getting better but still some discomfort.
8 days after a flu-like illness and 2 days, post vax, pt had numbness in his feet, progressing to GBS, arresting at waist and then descending. Still complaint of tingling in one foot. A letter from his neurologist, stated that he never told the pt that the "combination of kidney infection and influenza vaccine caused the GBS. In fact, after review of the records, it is not clear to me that the pt had a kidney infection at all (review of the records indicated that he presented with fever, generalized joint aches, headache, drowsiness and chills and no urinary symptoms, but generalized myalgias. He had a normal white count and although he did have some bacteria on urinalysis, he had no WBCs, negative leukocyte esterase activity and negative nitrates). My discussion with the pt was that in all likelihood he had a viral illness on 10/2/99 and that this was more likely the cause of his GBS than his flu vaccine. The onset of the numbness in his feet occurred on 10/10/00, 8 days after the flu-like illness but only 2 days after the flu shot, too short a time to have been related to the flu vaccine itself.
fatigue; muscle pain; chills; fever; Tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021 and was forwarded to Moderna on 07-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever) and FATIGUE (Tired) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever) and FATIGUE (Tired). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication information was provided   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Event outcome provided, declined further follow-up
Persistent headaches since vaccination day (every 3-5 days); sometimes with stomach pain/pain in center of spine. Medical appointment scheduled 3/2/2022.
visual disturbance; Initial information received on 24-Aug-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves an unknown age female patient who had visual disturbance after receiving yellow fever vaccine - [YF-VAX].  The patient's past medical history included Ophthalmic migraine. The patient's past medical treatment(s), vaccination(s) and family history were not provided. Patient does not have any other history of anything and is not currently on any other medications.  On 24-Aug-2023 at 11:30 A.M., the patient received unknown dose of suspect yellow fever vaccine, solution for injection (strength, batch number, expiry date unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization).  Information on the batch number was requested.  On 24-Aug-2023 (at around 1:30 P.M.) the patient had visual disturbance (visual impairment) (same day latency) following the administration of yellow fever vaccine.  Patient reported the visual disturbance lasted about an hour. Reporter stated the patient was on the way to the ophthalmologist for an evaluation, but the visual disturbance was already resolving. Patient also did not experience any reactions at the injection site or system related reactions.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (visual disturbance).  At time of reporting, the outcome was Recovered / Resolved on 24-Aug-2023 for the event visual disturbance.  No additional details.
c/o pain, fever (temp 105 degrees), swelling, redness, warmth of right deltoid within 24 hours of receiving Td. By 48 hours, fever had resolved; pain worsened with significant redness, swelling, warmth right deltoid by 72 degrees.
PATIENT DEVELOPED BELL'S PALSY 5 DAYS AFTER RECEIVING FLU MIST NASAL